Integer Holdings Corp (ITGR) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.

Total Revenue Chart for Integer Holdings Corp

Integer Holdings Corp (ITGR) revenue for FY2025 was USD 1.8B, a 7.6% change from FY2024. Integer Holdings Corp's revenue grew from USD 79.2M in 1999 to USD 1.8B in 2025 (2230.4% over 26 years). Earnings per share grew from USD 0.07 in 2000 to USD 1.99 in 2022 (2715.9%). Revenue compound annual growth rate: 5-year CAGR of 11.5%, 10-year CAGR of 8.7%, 20-year CAGR of 10.7%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$4.30B
Implied Share Price
$126.54
Enterprise Value
$5.64B
Revenue (TTM)
$1.84B
EBITDA
$347.70M
Profit Margin
6.97%
Trailing P/E
34.57
Forward P/E
22.42
Price/Book (MRQ)
2.50
Price/Sales (TTM)
2.33
EV/EBITDA
18.39
EV/Revenue
3.06
Dividend Yield
—
Book Value
$50.56
Free Cash Flow (FY2025)
$105.12M
Free Cash Flow Yield
2.44%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.